05/22/2026
"The rheumatologist is the one who understands these conditions. And we now have the tools to treat them ourselves."
At the 2026 ASGCT Annual Meeting, Dr. Guillermo J. Valenzuela joined a panel on delivering cell therapy through community sites — and made the case for something fundamental: ownership.
Own the patient. Build the relationships. Close the knowledge gap on CAR-NK and off-the-shelf therapies.
The era of outpatient cell therapy in rheumatology is approaching. At IRIS, we understand that the specialty needs to be ready.